Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix; Morris Sherman; Josep M. Llovet; Michel Beaugrand; Riccardo Lencioni; Andrew K. Burroughs; Erik Christensen; Luigi Pagliaro; Massimo Colombo; Juan Rodés

doi:10.1016/s0168-8278(01)00130-1

Related publications

Article2001

For the EASL Panel of Experts on hepatocellular carcinoma

Jordi Bruix, Morris Sherman, Josep M. Llovet, Michel Beaugrand, R Lenicioni, AK Burroughs, Emil Christensen, Lance C. Pagliaro, Massimo Colombo, J Rodés

Article2012

EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

Josep M. Llovet, Michel Ducreux, Riccardo Lencioni, Adrian M. Di Bisceglie, Jean‐François Dufour, Tim F. Greten, Éric Raymond, Tania Roskams, Vincenzo Mazzaferro, Jordi Bruix, Massimo Colombo, Andrew X. Zhu

Article2018

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean‐Luc Raoul, Peter Schirmacher, Valérie Vilgrain

Journal of Hepatology

Article2003

Hepatocellular carcinoma: a clinical update.

Fernando Pons-Renedo, Josep M. Llovet

PubMed

Article2020

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

Josep M. Llovet, Augusto Villanueva, Jorge A. Marrero, Myron Schwartz, Tim Meyer, Peter R. Galle, Riccardo Lencioni, Tim F. Greten, Masatoshi Kudo, Sumithra J. Mandrekar, Andrew X. Zhu, Richard S. Finn, Lewis R. Roberts

Hepatology